FIELD: mdicine, oncology, immunology. SUBSTANCE: invention relates to the treatment of patients with B-cellular lymphoma. Invention proposes a new immunologically active chimeric antibody - anti-C20 among them an antibody labeled with radioisotope and also a hybridoma producing an antibody showing specificity with respect to C20-antigen. Method of treatment involves the administration of indicated antibody preparations by three stages using different therapeutically effective amounts of these antibodies. EFFECT: enhanced specificity of effect on malignant cells. 15 cl, 3 tbl
Authors
Dates
1999-10-20—Published
1993-11-12—Filed